Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

6.390 +0.040 (+0.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Treace Medical Concepts, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference
From Treace Medical Concepts, Inc.
Via GlobeNewswire
5 Analysts Have This to Say About Treace Medical Concepts
Within the last quarter, Treace Medical Concepts (NASDAQ:TMCI) has observed the following analyst ratings: 
Via Benzinga
Treace Medical Shares Interim Data From Corrective Toe Surgery Trial
 
Via Benzinga
Why Treace Medical Concepts Stock Is Trading Lower
Treace Medical Concepts Inc (NASDAQ: TMCI) shares are trading lower by 8.48% to $21.05 Wednesday morning after the company announced a proposed $100 million common stock offering. What Happened? 
Via Benzinga
Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Why Treace Medical Concepts (TMCI) Shares Are Falling During Tuesday's After-Hours Session
Treace Medical Concepts Inc (NASDAQ: TMCI) shares are trading lower by 6.52% to $21.50 during Tuesday's after-hours session. The company announced a proposed $100 million common stock offering. 
Via Benzinga
Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock
From Treace Medical Concepts, Inc.
Via GlobeNewswire
NASDAQ:TMCI Shareholder Alert: Investigation over Potential Wrongdoing at Treace Medical Concepts, Inc.
San Diego, CA -- (SBWIRE) -- 01/27/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Treace Medical Concepts, Inc. 
Via SBWire
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating BRP, Alico, Treace, and Welltower and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents
From Treace Medical Concepts, Inc.
Via GlobeNewswire
NASDAQ:TMCI Investor Notice: Investigation over Possible Securities Laws Violations by Treace Medical Concepts, Inc.
San Diego, CA -- (SBWIRE) -- 12/05/2022 -- Treace Medical Concepts, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology
From Treace Medical Concepts, Inc.
Via GlobeNewswire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study
From Treace Medical Concepts, Inc.
Via GlobeNewswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
Treace Medical Concepts Reports Third Quarter 2022 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million. 
Via Benzinga
Treace Announces Participation in Upcoming Investor Conferences
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace to Report Third Quarter 2022 Financial Results on November 8, 2022
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Treace Medical Concepts Appoints New Directors
From Treace Medical Concepts, Inc.
Via GlobeNewswire
Where Treace Medical Concepts Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Treace Medical Concepts (NASDAQ:TMCI) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.